Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02699970 · ClinicalTrials.gov registry record
Instrument Precision Study for Validation of Philips Dx
A clinical trial of Pathology, sponsored by Philips Digital & Computational Pathology.
- Completed
- Registry status
- 399
- Enrollment target
- 1
- Study location
NCT02699970: Completed study of Pathology, sponsored by Philips Digital & Computational Pathology.
NCT02699970 is a study of Pathology that has completed, run by Philips Digital & Computational Pathology. The registered enrollment target is 399 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02699970, a study of Pathology, has completed, sponsored by Philips Digital & Computational Pathology.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate precision of the Philips Dx system.
Primary Outcome
The agreement rate between reads calculated over all selected features and pathologists. Readings were considered in agreement when the selected feature was indicated as 'present' or 'absent' in both readings.
Conditions Studied
Study Locations (1)
Massachusetts
- MGH - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-10 |
What the finished NCT02699970 record still lists
NCT02699970 is an observational study that tracks outcomes without assigning an intervention. The registered 399 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Pathology appearing as the primary indexed condition, and to 0 interventions.
NCT02699970 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02699970 about?
NCT02699970 is a clinical study titled "Instrument Precision Study for Validation of Philips Dx". The objective of this study is to evaluate precision of the Philips Dx system.
What is the current status of trial NCT02699970?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2016-02. Estimated completion is 2016-10.
What conditions does trial NCT02699970 study?
This clinical trial studies the following conditions: Pathology.
Who is sponsoring clinical trial NCT02699970?
This trial is sponsored by Philips Digital & Computational Pathology, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02699970 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pathology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia